0
     

Report Added
Report already added
Drugs for Schistosomiasis Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Drugs for Schistosomiasis Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty._x000D_
_x000D_
This report contains market size and forecasts of Drugs for Schistosomiasis in India, including the following market information:_x000D_
India Drugs for Schistosomiasis Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
India Drugs for Schistosomiasis Market Consumption, 2015-2020, 2021-2026, (M Units)_x000D_
India Drugs for Schistosomiasis Production Capacity, 2015-2020, 2021-2026, (M Units)_x000D_
Top Five Competitors in India Drugs for Schistosomiasis Market 2019 (%)_x000D_
The global Drugs for Schistosomiasis market was valued at 78 million in 2019 and is projected to reach US$ 90 million by 2026, at a CAGR of 3.6% during the forecast period. While the Drugs for Schistosomiasis market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Schistosomiasis manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas._x000D_
This report also analyses and evaluates the COVID-19 impact on Drugs for Schistosomiasis production and consumption in India_x000D_
Total Market by Segment:_x000D_
India Drugs for Schistosomiasis Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Units)_x000D_
India Drugs for Schistosomiasis Market Segment Percentages, By Type, 2019 (%)_x000D_
Praziquantel_x000D_
Oxamniquine_x000D_
Other_x000D_
_x000D_
India Drugs for Schistosomiasis Market, By Application, 2015-2020, 2021-2026 ($ millions) & (M Units)_x000D_
India Drugs for Schistosomiasis Market Segment Percentages, By Application, 2019 (%)_x000D_
S. haematobium_x000D_
S. mansoni_x000D_
S. japonicum_x000D_
S. mekongi_x000D_
S. intercalatum_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Drugs for Schistosomiasis Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Drugs for Schistosomiasis Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Total India Drugs for Schistosomiasis Market Competitors Sales, by Players 2015-2020 (Estimated), (M Units)_x000D_
Total India Drugs for Schistosomiasis Market Competitors Sales Market Share by Players 2019 ($ millions)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
Shin Poong_x000D_
Merck_x000D_
Bayer_x000D_
EIPICO_x000D_
Chandra Bhagat Pharma_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Drugs for Schistosomiasis Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Segment by Type_x000D_
1.2.2 Segment by Application_x000D_
1.3 India Drugs for Schistosomiasis Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 COVID-19 Impact: India Drugs for Schistosomiasis Overall Market Size_x000D_
2.1 India Drugs for Schistosomiasis Market Size: 2020 VS 2026_x000D_
2.2 India Drugs for Schistosomiasis Revenue, Prospects & Forecasts: 2015-2026_x000D_
2.3 India Drugs for Schistosomiasis Sales (Consumption): 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Drugs for Schistosomiasis Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Drugs for Schistosomiasis Companies Ranked by Revenue_x000D_
3.3 India Drugs for Schistosomiasis Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 India Drugs for Schistosomiasis Sales by Companies (including Foreign and Local Companies)_x000D_
3.5 India Drugs for Schistosomiasis Price by Manufacturer (2015-2020)_x000D_
3.6 Top 3 and Top 5 Drugs for Schistosomiasis Companies in India, by Revenue in 2019_x000D_
3.7 India Manufacturers Drugs for Schistosomiasis Product Type_x000D_
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Schistosomiasis Players in India_x000D_
3.8.1 List of India Tier 1 Drugs for Schistosomiasis Companies_x000D_
3.8.2 List of India Tier 2 and Tier 3 Drugs for Schistosomiasis Companies_x000D_
_x000D_
4 Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Drugs for Schistosomiasis Market Size Markets, 2020 & 2026_x000D_
4.1.2 Praziquantel_x000D_
4.1.3 Oxamniquine_x000D_
4.1.4 Other_x000D_
4.2 By Type - India Drugs for Schistosomiasis Revenue & Forecasts_x000D_
4.2.1 By Type - India Drugs for Schistosomiasis Revenue, 2015-2020_x000D_
4.2.2 By Type - India Drugs for Schistosomiasis Revenue, 2021-2026_x000D_
4.2.3 By Type - India Drugs for Schistosomiasis Revenue Market Share, 2015-2026_x000D_
4.3 By Type - India Drugs for Schistosomiasis Sales & Forecasts_x000D_
4.3.1 By Type - India Drugs for Schistosomiasis Sales, 2015-2020_x000D_
4.3.2 By Type - India Drugs for Schistosomiasis Sales, 2021-2026_x000D_
4.3.3 By Type - India Drugs for Schistosomiasis Sales Market Share, 2015-2026_x000D_
4.4 By Type - India Drugs for Schistosomiasis Price (Manufacturers Selling Prices), 2015-2026_x000D_
5 Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Drugs for Schistosomiasis Market Size, 2020 & 2026_x000D_
5.1.2 S. haematobium_x000D_
5.1.3 S. mansoni_x000D_
5.1.4 S. japonicum_x000D_
5.1.5 S. mekongi_x000D_
5.1.6 S. intercalatum_x000D_
5.2 By Application - India Drugs for Schistosomiasis Revenue & Forecasts_x000D_
5.2.1 By Application - India Drugs for Schistosomiasis Revenue, 2015-2020_x000D_
5.2.2 By Application - India Drugs for Schistosomiasis Revenue, 2021-2026_x000D_
5.2.3 By Application - India Drugs for Schistosomiasis Revenue Market Share, 2015-2026_x000D_
5.3 By Application - India Drugs for Schistosomiasis Sales & Forecasts_x000D_
5.3.1 By Application - India Drugs for Schistosomiasis Sales, 2015-2020_x000D_
5.3.2 By Application - India Drugs for Schistosomiasis Sales, 2021-2026_x000D_
5.3.3 By Application - India Drugs for Schistosomiasis Sales Market Share, 2015-2026_x000D_
5.4 By Application - India Drugs for Schistosomiasis Price (Manufacturers Selling Prices), 2015-2026_x000D_
6 Manufacturers & Brands Profiles_x000D_
6.1 Shin Poong_x000D_
6.1.1 Shin Poong Corporate Summary_x000D_
6.1.2 Shin Poong Business Overview_x000D_
6.1.3 Shin Poong Drugs for Schistosomiasis Major Product Offerings_x000D_
6.1.4 Shin Poong Sales and Revenue in India (2015-2020)_x000D_
6.1.5 Shin Poong Key News_x000D_
6.2 Merck_x000D_
6.2.1 Merck Corporate Summary_x000D_
6.2.2 Merck Business Overview_x000D_
6.2.3 Merck Drugs for Schistosomiasis Major Product Offerings_x000D_
6.2.4 Merck Sales and Revenue in India (2015-2020)_x000D_
6.2.5 Merck Key News_x000D_
6.3 Bayer_x000D_
6.3.1 Bayer Corporate Summary_x000D_
6.3.2 Bayer Business Overview_x000D_
6.3.3 Bayer Drugs for Schistosomiasis Major Product Offerings_x000D_
6.3.4 Bayer Sales and Revenue in India (2015-2020)_x000D_
6.3.5 Bayer Key News_x000D_
6.4 EIPICO_x000D_
6.4.1 EIPICO Corporate Summary_x000D_
6.4.2 EIPICO Business Overview_x000D_
6.4.3 EIPICO Drugs for Schistosomiasis Major Product Offerings_x000D_
6.4.4 EIPICO Sales and Revenue in India (2015-2020)_x000D_
6.4.5 EIPICO Key News_x000D_
6.5 Chandra Bhagat Pharma_x000D_
6.5.1 Chandra Bhagat Pharma Corporate Summary_x000D_
6.5.2 Chandra Bhagat Pharma Business Overview_x000D_
6.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Major Product Offerings_x000D_
6.5.4 Chandra Bhagat Pharma Sales and Revenue in India (2015-2020)_x000D_
6.5.5 Chandra Bhagat Pharma Key News_x000D_
6.6 Taj Pharmaceuticals_x000D_
6.6.1 Taj Pharmaceuticals Corporate Summary_x000D_
6.6.2 Taj Pharmaceuticals Business Overview_x000D_
6.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Major Product Offerings_x000D_
6.6.4 Taj Pharmaceuticals Sales and Revenue in India (2015-2020)_x000D_
6.6.5 Taj Pharmaceuticals Key News_x000D_
_x000D_
7 Drugs for Schistosomiasis Production Capacity, Export and Import Analysis_x000D_
7.1 Drugs for Schistosomiasis Production Capacity and Value in India, Situation Analysis and Prediction, 2015-2026_x000D_
7.1.1 India Drugs for Schistosomiasis Production Capacity, 2015-2026_x000D_
7.1.2 India Drugs for Schistosomiasis Production 2015-2026_x000D_
7.1.3 India Drugs for Schistosomiasis Production Value 2015-2026_x000D_
7.2 Key Local Drugs for Schistosomiasis Manufacturers in India_x000D_
7.2.1 India Key Local Drugs for Schistosomiasis Manufacturers Production Capacity_x000D_
7.2.2 India Key Local Drugs for Schistosomiasis Manufacturers Production_x000D_
7.2.3 India Key Local Drugs for Schistosomiasis Manufacturers Production Value_x000D_
7.2.4 The Proportion of Drugs for Schistosomiasis Production Sold in India and Sold Other Than India by Manufacturers_x000D_
7.3 Drugs for Schistosomiasis Export and Import in India_x000D_
7.3.1 India Drugs for Schistosomiasis Export Market_x000D_
7.3.2 India Drugs for Schistosomiasis Source of Imports_x000D_
_x000D_
8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints_x000D_
8.1 PESTLE Analysis for India Drugs for Schistosomiasis Market_x000D_
8.2 Market Opportunities & Trends_x000D_
8.3 Market Drivers_x000D_
8.4 Market Restraints_x000D_
_x000D_
9 COVID-19 Impact on Drugs for Schistosomiasis Supply Chain Analysis_x000D_
9.1 Supply Chain Analysis_x000D_
9.2 Upstream Market Analysis_x000D_
9.3 Downstream and Clients Market Analysis_x000D_
9.4 Marketing Channels Analysis_x000D_
9.4.1 Marketing Channels_x000D_
9.4.2 Drugs for Schistosomiasis Distributors and Sales Agents in India_x000D_
_x000D_
10 Conclusion_x000D_
_x000D_
11 Appendix_x000D_
11.1 Note_x000D_
11.2 Examples of Clients_x000D_
11.3 Disclaimer_x000D_
List of Tables_x000D_
Table 1. Key Players of Drugs for Schistosomiasis in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Drugs for Schistosomiasis Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Drugs for Schistosomiasis Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Drugs for Schistosomiasis Sales by Companies, (M Units), 2015-2020_x000D_
Table 6. India Drugs for Schistosomiasis Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Drugs for Schistosomiasis Price (2015-2020) (USD/K Units)_x000D_
Table 8. India Manufacturers Drugs for Schistosomiasis Product Type_x000D_
Table 9. List of India Tier 1 Drugs for Schistosomiasis Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Drugs for Schistosomiasis Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Drugs for Schistosomiasis Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Drugs for Schistosomiasis Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Drugs for Schistosomiasis Sales in India (M Units), 2015-2020_x000D_
Table 14. By Type - Drugs for Schistosomiasis Sales in India (M Units), 2021-2026_x000D_
Table 15. By Application - Drugs for Schistosomiasis Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Drugs for Schistosomiasis Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Drugs for Schistosomiasis Sales in India, (M Units), 2015-2020_x000D_
Table 18. By Application - Drugs for Schistosomiasis Sales in India, (M Units), 2021-2026_x000D_
Table 19. Shin Poong Corporate Summary_x000D_
Table 20. Shin Poong Drugs for Schistosomiasis Product Offerings_x000D_
Table 21. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 22. Merck Corporate Summary_x000D_
Table 23. Merck Drugs for Schistosomiasis Product Offerings_x000D_
Table 24. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 25. Bayer Corporate Summary_x000D_
Table 26. Bayer Drugs for Schistosomiasis Product Offerings_x000D_
Table 27. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 28. EIPICO Corporate Summary_x000D_
Table 29. EIPICO Drugs for Schistosomiasis Product Offerings_x000D_
Table 30. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 31. Chandra Bhagat Pharma Corporate Summary_x000D_
Table 32. Chandra Bhagat Pharma Drugs for Schistosomiasis Product Offerings_x000D_
Table 33. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 34. Taj Pharmaceuticals Corporate Summary_x000D_
Table 35. Taj Pharmaceuticals Drugs for Schistosomiasis Product Offerings_x000D_
Table 36. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 37. Drugs for Schistosomiasis Production Capacity (M Units) of Local Manufacturers in India, 2015-2020_x000D_
Table 38. Drugs for Schistosomiasis Production (M Units) of Local Manufacturers in India, 2015-2020_x000D_
Table 39. India Drugs for Schistosomiasis Production Market Share of Local Manufacturers, 2015-2020_x000D_
Table 40. Drugs for Schistosomiasis Production Value (US$, Mn) of Local Manufacturers in India, 2015-2020_x000D_
Table 41. India Drugs for Schistosomiasis Production Value Market Share of Local Manufacturers, 2015-2020_x000D_
Table 42. The Percentage of Drugs for Schistosomiasis Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 43. The Percentage of Drugs for Schistosomiasis Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 44. Dangeguojia Drugs for Schistosomiasis Sales (Consumption), Production, Export and Import, 2015-2020_x000D_
Table 45. Raw Materials and Suppliers_x000D_
Table 46. Drugs for Schistosomiasis Downstream Clients in India_x000D_
Table 47. Drugs for Schistosomiasis Distributors and Sales Agents in India_x000D_
List of Figures_x000D_
Figure 1. Drugs for Schistosomiasis Segment by Type_x000D_
Figure 2. Drugs for Schistosomiasis Segment by Application_x000D_
Figure 3. Dangeguojia Drugs for Schistosomiasis Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Drugs for Schistosomiasis Market Size in India, (US$, Mn) & (M Units): 2020 VS 2026_x000D_
Figure 6. India Drugs for Schistosomiasis Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. Drugs for Schistosomiasis Sales in India: 2015-2026 (M Units)_x000D_
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Schistosomiasis Revenue in 2019_x000D_
Figure 9. By Type - India Drugs for Schistosomiasis Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 10. By Type - India Drugs for Schistosomiasis Market Share, 2015-2020_x000D_
Figure 11. By Type - India Drugs for Schistosomiasis Market Share, 2020-2026_x000D_
Figure 12. By Type - India Drugs for Schistosomiasis Price (USD/K Units), 2015-2026_x000D_
Figure 13. By Application - Drugs for Schistosomiasis Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 14. By Application - India Drugs for Schistosomiasis Market Share, 2015-2020_x000D_
Figure 15. By Application - India Drugs for Schistosomiasis Market Share, 2020-2026_x000D_
Figure 16. By Application -India Drugs for Schistosomiasis Price (USD/K Units), 2015-2026_x000D_
Figure 17. India Drugs for Schistosomiasis Production Capacity (M Units), 2015-2026_x000D_
Figure 18. India Drugs for Schistosomiasis Actual Output (M Units), 2015-2026_x000D_
Figure 19. India Drugs for Schistosomiasis Production Value (US$, Mn), 2015-2026_x000D_
Figure 20. The Percentage of India Drugs for Schistosomiasis Export Destination, 2019_x000D_
Figure 21. The Source of Imports of India Drugs for Schistosomiasis, 2019_x000D_
Figure 22. PEST Analysis for India Drugs for Schistosomiasis Market in 2020_x000D_
Figure 23. Drugs for Schistosomiasis Market Opportunities & Trends in India_x000D_
Figure 24. Drugs for Schistosomiasis Market Drivers in India_x000D_
Figure 25. Drugs for Schistosomiasis Market Restraints in India_x000D_
Figure 26. Drugs for Schistosomiasis Industry Value Chain_x000D_

Kindly Fill The Form Below

Report Title: Drugs for Schistosomiasis Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW